PGD conditions awaiting consideration
Preimplantation genetic diagnosis (PGD) is a technique that enables people with a specific inherited condition in their family to avoid passing it on to their children. It involves checking the genes of embryos created through IVF for this genetic condition.
If a clinic wishes to use Preimplantation genetic diagnosis (PGD) to test for a new genetic condition, then it must apply to the HFEA for permission.
You can sign up to our PGD update email alert service which will keep you up to date, on a monthly basis, with information on the latest conditions added to the authorised list and conditions that are awaiting approval about which you can provide comments.
The following conditions are those which the HFEA is considering to allow clinics to use PGD to test for:
|Genetic condition||OMIM number1||Submit feedback to the HFEA by:|
|Episodic Ataxia Type 2||108500||19/09/2014|
|Osteogenesis Imperfecta Type VIII||610915||19/09/2014|
|Meckel-Gruber Syndrome Type 1, Type 2, Type 4, Type 5, Type 6, Type 7, Type 8, Type 9, Type 10, Type 11||249000, 603194, 611134, 611561, 612284, 267010, 613885, 614209, 614175, 615397||19/09/2014|
|Juvenile Polyposis Syndrome||174900||19/09/2014|
|Familial Dilated Cardiomyopathy||191045||19/09/2014|
|Retinitis Pigmentosa 11||600138||19/09/2014|
|Hyperphosphatasia with mental retardation syndrome 4||615716||26/08/2014|
Have your say on conditions awaiting consideration
If you have any feedback on the genetic conditions awaiting consideration by the HFEA, send us an email and we will discuss your comments at the next Licence Committee.
Email your feedback to: firstname.lastname@example.org
You can also sign up to our PGD update email alert service which will keep you up to date, on a monthly basis, with information on the latest conditions added to the authorised list and conditions that are awaiting approval about which you can provide comments.
Page last updated: 13 August 2014